twelve patients affected by different types of acute leukemia received idarubicin ( 4-demethoxy-daunorubicin ) by oral route at the total dosage of 45 , 60 or 90 mg/m2 distributed over three consecutive days .
C0020789
idarubicin
C0011015
daunorubicin